DRKS00023929已完成不适用
Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
Allgemein- und Viszeralchirurgie Uniklinik Freiburg0 个研究点目标入组 14 人开始时间: 2020年12月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Primary resectable pancreatic ductal adenocarcinoma
排除标准
- •Other tumor entities in pt. history
研究者
相似试验
进行中（未招募）
不适用
Identification of predictive plasma Biomarkers and use of a high dosage statin during a procedure of Parrossistic Atrial Fibrillation CardioversioEUCTR2012-001260-29-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO
已完成
不适用
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal CancerResectable Esophageal CancerNCT01858805Universitätsklinikum Hamburg-Eppendorf123
已完成
不适用
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung cancer, an exploratory studyNon-small cell lung cancer (NSCLC)10038666NL-OMON45880niversitair Medisch Centrum Groningen40
尚未招募
不适用
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung canceron-small cell lung cancer, KRAS mutationNiet-kleincellig longkanker, KRAS mutatieNL-OMON25545niversity Medical Center Groningen40
已完成
Unknown
INTENT_Circulating tumor cells as biomarkers for recurrence risk in thermoablatioC22.0Liver cell carcinomaDRKS00016808Klinikum der Universität München, Campus Großhadern100